Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life

Despite the common use of Thimerosal as a preservative in childhood vaccines since the 1930s, there are not many studies on ethylmercury toxicokinetics and toxicodynamics in infants. The knowledge of ethylmercury\'s potential adverse effects is derived mostly from parallel methylmercury research or from animal and theoretical models. This study was designed to examine the relationship between neonatal exposure to Thimerosal-containing vaccine (TCV) and child development.